Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Luo, Yuesheng; Liu, Leilei; Liu, Daihong; Shen, Hesong; Wang, Xiaoxia; Fan, Chunbo; Zeng, Zhen; Zhang, Jing et al. · Eur Radiol · 2023

retrospective_cohort · Level III

Where this comes from

Abstract

To determine the extracellular volume (ECV) fraction derived from equilibrium contrast-enhanced CT for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer (LARC). The ECV fraction before NCRT (ECV<sub>pre)</sub> and/or ECV after NCRT (ECV<sub>post</sub>) of rectal tumors was assessed, and ECV<sub>Δ</sub> was calculated as ECV<sub>post</sub> - ECV<sub>pre</sub>. The histopathologic tumor regression grading (TRG) was assessed. pCR (TRG 0 grade) was defined as the absence of viable tumor cells in the primary tumor and lymph nodes. Demographic and clinicopathological characteristics and ECV fraction were compared between the pCR and non-pCR groups. A mixed model was constructed by logistic regression. The performance for predicting pCR was assessed with the area under the receiver-operator curve (AUC). The AUCs of the different methods were compared by the method proposed by DeLong et al. RESULTS: Seventy-five patients were included; 17 achieved pCR, and 58 achieved non-pCR. The ECV<sub>post</sub> (17.05 ± 2.36% vs. 29.94 ± 1.20%; p < 0.001) and ECV<sub>Δ</sub> (- 17.01 ± 3.01% vs. 0.44 ± 1.45%; p < 0.001) values in the pCR group were significantly lower than those in the non-pCR group. The mixed model that combined ECV<sub>post</sub> with ECV<sub>Δ</sub> achieved an AUC of 0.92 (95% confidence interval (CI) = 0.81-0.98), which was higher than that of ECV<sub>post</sub> (AUC, 0.91 (95% CI = 0.80-0.97); p = 0.60) or ECV<sub>Δ</sub> (AUC, 0.90 (95% CI = 0.79-0.97); p = 0.61). ECV<sub>post</sub> and ECV<sub>Δ</sub> determined by using equilibrium contrast-enhanced CT were useful in distinguishing between pCR and non-pCR patients with LARC who received NCRT. • ECV<sub>post</sub> and ECV<sub>Δ</sub> (ECV<sub>post</sub> - ECV<sub>pre</sub>) differed significantly between the non-pCR and pCR groups. • ECV<sub>pre</sub> cannot be used to predict the efficacy of neoadjuvant chemoradiotherapy. • ECV<sub>post</sub> combined with ECV<sub>Δ</sub> had the best performance with an AUC of 0.92 for predicting pCR after NCRT in LARC.

Medical subject headings